LTRN
Price
$3.80
Change
+$0.06 (+1.60%)
Updated
Mar 14 closing price
Capitalization
40.98M
2 days until earnings call
XOMAO
Price
$25.41
Change
-$0.01 (-0.04%)
Updated
Mar 14 closing price
Capitalization
N/A
Ad is loading...

LTRN vs XOMAO

Header iconLTRN vs XOMAO Comparison
Open Charts LTRN vs XOMAOBanner chart's image
Lantern Pharma
Price$3.80
Change+$0.06 (+1.60%)
Volume$24.29K
Capitalization40.98M
XOMA
Price$25.41
Change-$0.01 (-0.04%)
Volume$722
CapitalizationN/A
LTRN vs XOMAO Comparison Chart
Loading...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LTRN vs. XOMAO commentary
Mar 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LTRN is a Hold and XOMAO is a Buy.

Ad is loading...
COMPARISON
Comparison
Mar 16, 2025
Stock price -- (LTRN: $3.80 vs. XOMAO: $25.41)
Brand notoriety: LTRN and XOMAO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LTRN: 25% vs. XOMAO: 37%
Market capitalization -- LTRN: $40.98M vs. XOMAO: $0
LTRN [@Biotechnology] is valued at $40.98M. XOMAO’s [@Biotechnology] market capitalization is $0. The market cap for tickers in the [@Biotechnology] industry ranges from $340.08B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LTRN’s FA Score shows that 1 FA rating(s) are green whileXOMAO’s FA Score has 1 green FA rating(s).

  • LTRN’s FA Score: 1 green, 4 red.
  • XOMAO’s FA Score: 1 green, 4 red.
According to our system of comparison, both LTRN and XOMAO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LTRN’s TA Score shows that 5 TA indicator(s) are bullish.

  • LTRN’s TA Score: 5 bullish, 5 bearish.

Price Growth

LTRN (@Biotechnology) experienced а +3.83% price change this week, while XOMAO (@Biotechnology) price change was -0.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.40%. For the same industry, the average monthly price growth was -6.10%, and the average quarterly price growth was -7.72%.

Reported Earning Dates

LTRN is expected to report earnings on May 06, 2025.

Industries' Descriptions

@Biotechnology (-1.40% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LTRN YTD gains are higher at: 19.122 vs. XOMAO (1.091). XOMAO has higher annual earnings (EBITDA): -18.71M vs. LTRN (-21.18M). XOMAO has more cash in the bank: 93.3M vs. LTRN (28.1M). LTRN has less debt than XOMAO: LTRN (291K) vs XOMAO (119M). XOMAO has higher revenues than LTRN: XOMAO (9.71M) vs LTRN (0).
LTRNXOMAOLTRN / XOMAO
Capitalization41MN/A-
EBITDA-21.18M-18.71M113%
Gain YTD19.1221.0911,753%
P/E RatioN/AN/A-
Revenue09.71M-
Total Cash28.1M93.3M30%
Total Debt291K119M0%
TECHNICAL ANALYSIS
Technical Analysis
LTRN
RSI
ODDS (%)
Bullish Trend 2 days ago
89%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
LTRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JMVNX14.43N/A
N/A
JHFunds2 Mid Value NAV
PRMSX34.69N/A
N/A
T. Rowe Price Emerging Markets Stock
SCOBX40.66N/A
N/A
DWS International Growth S
HSZAX5.16N/A
N/A
NexPoint Climate Tech A
GSVPX15.02N/A
N/A
Goldman Sachs Small/Mid Cap Value P

LTRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LTRN has been loosely correlated with AXON. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if LTRN jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LTRN
1D Price
Change %
LTRN100%
+1.60%
AXON - LTRN
36%
Loosely correlated
+4.06%
GLYC - LTRN
34%
Loosely correlated
+3.08%
INZY - LTRN
32%
Poorly correlated
+1.03%
MNMD - LTRN
32%
Poorly correlated
+0.63%
ORMP - LTRN
31%
Poorly correlated
N/A
More

XOMAO and

Correlation & Price change

A.I.dvisor indicates that over the last year, XOMAO has been closely correlated with AMLX. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if XOMAO jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMAO
1D Price
Change %
XOMAO100%
-0.03%
AMLX - XOMAO
68%
Closely correlated
-1.09%
ATAI - XOMAO
24%
Poorly correlated
+6.47%
LTRN - XOMAO
23%
Poorly correlated
+1.60%
KALV - XOMAO
23%
Poorly correlated
+2.94%
APLM - XOMAO
23%
Poorly correlated
-3.87%
More